Close Menu

cytogenetics

Name: Anwar Iqbal
Title: Director of microarray CGH laboratory, department of pathology, University of Rochester Medical Center

Agilent Technologies and PerkinElmer have signed an agreement that will see PerkinElmer's Signature Genomics business switch to Agilent arrays for its genetic testing services.

A recent survey has found that laboratories differ in how they report findings indicating parental relatedness back to clinicians caring for patients with constitutional abnormalities.

Cytogeneticists are increasingly adopting chromosomal microarrays for prenatal diagnostics, but have not yet reached a consensus when it comes to what kinds of cases should undergo array-based screening and which platform is best to use.

A growing number of cytogeneticists are joining a new entity called the Cytogenomics Array Group to share data related to abnormal microarray findings.

Agilent Technologies now claims its comparative genomic hybridization arrays can be used for single-cell analysis.

Name: Dom McMullan
Title: Head of Molecular Cytogenetics, West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust

NUREMBERG, Germany — An Affymetrix executive this week affirmed the company's intention to submit its CytoScan HD to the US Food and Drug Administration by the end of this year, and said that it will have the product certified as an in vitro diagnostic in Europe in the s

NUREMBERG, Germany — Oxford Gene Technology will soon add another cancer-focused array to its menu of CytoSure chips for cytogenetic research. Separately, the company is planning extensions to its Genefficiency sequencing services.

Name: Jacqueline Schoumans
Title: Head of Cancer Cytogenetic Unit, University of Lausanne

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.